Association between C-reactive protein and coronary calcium score in coronary artery disease

Cardiovascular Journal of Africa

Volumn 20, Issue 2, 2009, Pages 107-111

  Hosseinsabet, Ali ^a   Mohebbi, Ahmad ^a   Almasi, Alireza ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; TISSUE LEVEL;

AGED; CALCINOSIS; CALCIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID HORMONE RECEPTORS ALPHA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67549088069     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37: 1923-1932. (Pubitemid 44297753)
2. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003; 10: 63-71.
3. Niccoli G, Biasucci LM, Biscione C, Fusco B, Porto I, Leone AM, et al. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2008; 196: 779-785.
4. Zhang SZ, Jin YP, Qin GM, Wang JH. Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes. Clin Cardiol 2007; 30: 26-31. (Pubitemid 46147606)
5. Correia LC, Lima JC, Rocha MS, D'Oliveira A (jun), Péricles Esteves J. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-risk score in individuals with non-ST elevation acute coronary syndromes? Clin Chim Acta 2007; 375: 124-128. (Pubitemid 44584232)
6. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 2006; 109: 248-256.
7. Sanchez PL, Morinigo JL, Pabon P, Martin F, Piedra I, Palacios IF, Martin-Luengo C. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome. Heart 2004; 90: 264-269. (Pubitemid 38250715)
8. Zairis MN, Adamopoulou EN, Manousakis SJ, Lyras AG, Bibis GP, Ampartzidou OS, et al. Biomarkers of Inflammation and Outcome in acute coronary Syndromes (BIAS) investigators. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes. Atherosclerosis 2007; 194: 397-402.
9. Onat A, Can G, Hergenç G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 2008; 57: 207-214.
10. Hung J, Knuiman MW, Divitini ML, Davis T, Beilby JP. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol 2008; 101: 193-198.
11. Tohidi M, Hadaegh F, Harati H, Azizi F. C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Int J Cardiol e-publ, 2008.
12. Arena R, Arrowood JA, Fei DY, Helm S, Kraft KA. The relationship between C-reactive protein and other cardiovascular risk factors in men and women. J Cardiopulm Rehabil 2006; 26: 323-327. (Pubitemid 44465631)
13. Raitakari M, Mansikkaniemi K, Marniemi J, Viikari JS, Raitakari OT. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study. J Intern Med 2005; 258: 428-434. (Pubitemid 41546558)
14. Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord 2004; 28: 998-1003. (Pubitemid 38998705)
15. Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis 2007; 194: 238-244. (Pubitemid 47464303)
16. Wang TJ, Martin G, Larson GM, Levy D, Benjamin EJ, Kupka MJ, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women The Framingham Heart Study. Circulation 2002; 106: 1189-1191. (Pubitemid 34988633)
17. Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CDA. C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 2002; 25: 1813-1817. (Pubitemid 41071092)
18. Erbel R, Mohlenkamp S, Lehmann N, Schmermund A, Moebus S, Stang A, et al., on behalf of the Heinz Nixdorf Recall Study investigative group. Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis 2008; 197: 662-672.
19. Hunt ME, O'Malley PG, Vernalis MN, Feuerstein IM, and Taylor AJ. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 2001; 141: 206-210. (Pubitemid 32128724)
20. Newman AB, Barbara L, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH. Coronary artery calcification in older adults to age 99 prevalence and risk factors. Circulation 2001; 104: 2679-2684. (Pubitemid 33108133)
21. Reilly MP, Wolfe ML, Russell Localio A, Rader DJ. C-reactive protein and coronary artery calcification.The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003; 23: 1851-1856. (Pubitemid 37254874)
22. Arad Y, Goodman JK, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events .The St. Francis Heart Study. J Am Coll Cardiol 2005; 46: 158-165. (Pubitemid 40905145)
23. Huang HP, Chen LC, Leu HB, Ding PY, Jaw-Wen Chen JW, Wu TC, Lin SJ. Enhanced coronary calcification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest 2005; 128: 810-815. (Pubitemid 41140513)
24. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, Wians FH, Grundy SM , McGuire DK. Relationship between C-reactive protein and subclinical atherosclerosis. The Dallas Heart Study. Circulation 2006; 113: 38-43. (Pubitemid 43958486)
25. Anand DV, Lim E, Darko D, Hopkins PBD, Lipkin D, Corder R, Lahiri A. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol 2007; 50: 2218-2225. (Pubitemid 350166815)
26. Coutinho TA, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007; 20: 83-89. (Pubitemid 46014067)
27. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JCM. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007; 195: e195-e202. (Pubitemid 350087990)
28. Redberg RF, Rifai N, Gee L, Ridker PM. Lack of association of C-Reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: Implications for coronary artery disease screening. J Am Coll Cardiol 2000; 36: 39-43. (Pubitemid 30466109)
29. Godsland IF, Elkeles RS, Feher MD, Nugara F, Rubens MB, Richmond W, et al., for the PREDICT study group. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabetes Med 2006; 23: 1192-1200. (Pubitemid 44600580)
30. Mullenix PS, Steele SR, Martin MJ, Starnes BW, Andersen CA. C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg 2007; 142: 1066-1071. (Pubitemid 350157043)
31. Schlager O, Exner M, Mlekusch W, Sabeti S, Amighi J, Dick P, et al. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke 2007; 38: 1263-1268. (Pubitemid 351664261)
32. Sander K, Horn CS, Briesenick C, Sander D; INVADE study group. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study. Stroke 2007; 38: 2881-2886. (Pubitemid 350035679)
33. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, et al. Association of carotid artery intima-media thickness, plaques, and Creactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007; 116: 32-38. (Pubitemid 47016244)
34. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007; 99: 1598-1602. (Pubitemid 46773027)
35. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007; 38: 1774-1779. (Pubitemid 46847246)
36. Arthurs ZM, Andersen C, Starnes BW, Sohn VY, Mullenix PS, Perry JA. Prospective evaluation of C-reactive protein in the progression of carotid artery stenosis. J Vasc Surg 2008 ; 47: 744-750.
37. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 1995; 92: 2157-2162.
38. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999; 74: 243-252. (Pubitemid 29135631)
39. Möhlenkamp S, Lehmann N, Schmermund A, Pump H, Moebus S, Baumgart D, et al. Prognostic value of extensive coronary calcium quantities in symptomatic males - a 5-year follow-up study. Eur Heart J 2003; 24: 845-854. (Pubitemid 36528564)
40. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as 'low risk' based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 2007; 167: 2437-2442.
41. Becker A, Leber A, Becker C, Knez A. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals. Am Heart J 2008; 155: 154-160. (Pubitemid 350237677)
42. Park R, Detrano R, Xiang M, Fu P, Ibrahim Y, LaBree L, Azen S. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 2002; 106: 2073-2077. (Pubitemid 35192813)
43. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transpl 2001; 16: 1189-1197. (Pubitemid 32547374)
44. Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004; 43: 244-253. (Pubitemid 38146322)
45. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int 2005; 68: 1258-1266. (Pubitemid 43246445)
46. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832. (Pubitemid 20101575)
47. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-1170. (Pubitemid 38880003)
48. Shankar A, Li J, Nieto FJ, Klein BE, Klein R. Association between Creactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 2007; 154: 495-501. (Pubitemid 47268244)